Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion
Purpose To evaluate the efficacy and safety of sequential therapy with ranibizumab followed by dexamethasone intravitreal implant compared with dexamethasone monotherapy for macular oedema (MO) secondary to retinal vein occlusion (RVO). Methods In this retrospective interventional study, the medical...
Main Authors: | Iu, L, Zhao, P, Yeung, I, Fung, N, Lee, J, Wong, R, Chong, V, Wong, I |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BMJ Publishing Group
2014
|
Registos relacionados
-
Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
Por: Xuemei Liang, et al.
Publicado em: (2022-09-01) -
Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
Por: Ayşe Ergin, et al.
Publicado em: (2022-12-01) -
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Por: S. K. Mishra, et al.
Publicado em: (2018-03-01) -
A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
Por: Alper Halil Bayat, et al.
Publicado em: (2019-12-01) -
Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
Por: Frederic Matonti, et al.
Publicado em: (2012-10-01)